Figure 2
From: S100A12 is a promising biomarker in papillary thyroid cancer
Knockdown of S100A12 inhibits PTC cells growth. (A) Western blot assay evaluated the S100A12 protein after transfected with shRNA#1 and shRNA#2 in TPC1 and K1 cells. (B) MTT assay showed that downregulation of S100A12 decreased the growth rate of PTC cells. *P < 0.05. (C) Silencing S100A12 significantly reduced the colony number in the colony formation assay. **P < 0.01. (D) S100A12 knockdown inhibits migration of TPC1and K1 cells. All data are demonstrated as a mean ± SD of three independent experiments. **P < 0.01.
